Overview

Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study

Status:
Completed

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

This is a pilot study to compare the relative bioavailability between two peppermint oil formulations, namely a colon-targeted-delivery capsule (Tempocol-ColoPulse®) and an enteric-coated capsule (Tempocol®). This study is conducted as part of a future multicenter randomized controlled trial that will assess the therapeutic effect of the new peppermint oil formulation in IBS patients.

Phase:

Phase 2

Details

Lead Sponsor:

Maastricht University Medical Center

Collaborator:

ZonMw: The Netherlands Organisation for Health Research and Development

Treatments:

Peppermint oil